Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ORKA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ORKA investment potential.

What is ORKA stock price today?

Get real-time ORKA stock price, historical data, and price charts on Financhill. Track ORKA performance with our advanced analysis tools.

Is ORKA a good investment?

Evaluate ORKA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ORKA stock?

To buy ORKA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ORKA?

View detailed market capitalization data and company valuation metrics for ORKA on our comprehensive analysis page.

What is the P/E ratio of ORKA?

Use our fundamental analysis tools to view ORKA P/E ratio and compare valuation metrics with industry peers.

What are ORKA earnings?

View ORKA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Oruka Therapeutics, Inc. Stock Predictions

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Sell

ORKA
Oruka Therapeutics, Inc.

Last Price:

$31.34

Seasonality Move:

-8.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Exxon and Chevron Have an Unlikely New Competitor

Oruka Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Oruka Therapeutics, Inc. has on average historically fallen by 12.4% based on the past 28 years of stock performance.
Oruka Therapeutics, Inc. has fallen lower in 23 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 82.14%
Is Oruka Therapeutics, Inc. Stock Undervalued?

The current Oruka Therapeutics, Inc. [ORKA] share price is $31.34. The Score for ORKA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
ORKA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Oruka Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Oruka Therapeutics, Inc. has on average historically fallen by 12.4% based on the past 28 years of stock performance.

Oruka Therapeutics, Inc. Stock Rating

Sell

Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. overpriced?

Oruka Therapeutics, Inc. has fallen lower in 23 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 82.14%

Oruka Therapeutics, Inc. Stock Price History

Is ORKA stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

orukatx.com

52-Week Data

52-Week High:

32.64

52-Week Low:

5.49

Prediction Charts

Market Cap:

1.5B

Price in USD:

31.34

Volume:

392.3K

Beta:

1.71

Technical Analysis

SMA50:

29.12

SMA100:

24.37

SMA200:

18.05

52-Wk Change:

123.46%

Stock Predictions

Is Oruka Therapeutics, Inc. stock public?

Yes, Oruka Therapeutics, Inc. is a publicly traded company.
What is the Oruka Therapeutics, Inc. stock quote today?

The Oruka Therapeutics, Inc. stock price is 31.34 USD today.
How to buy Oruka Therapeutics, Inc. stock online?

You can buy Oruka Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-22	31.26	31.97	32.62	30.05
Dec-23	31.62	31.71	32.64	30.88
Dec-24	31.95	32.12	32.43	31.56
Dec-26	32.00	31.70	32.25	30.31
Dec-29	31.52	30.90	31.82	30.36
Dec-30	30.83	29.12	30.90	28.15
Dec-31	29.12	30.31	30.81	29.09
Jan-5	28.05	26.88	28.05	25.23
Jan-6	26.81	26.62	26.93	25.89
Jan-7	27.27	27.81	28.51	26.78
Jan-8	27.56	26.40	27.76	25.79
Jan-9	26.60	27.86	28.16	26.46
Jan-12	27.74	30.69	30.78	26.91
Jan-13	31.56	31.34	31.56	29.66

Oruka Therapeutics, Inc. Earnings

Oruka Therapeutics, Inc. Earnings Report: Per Share Oruka Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Oruka Therapeutics, Inc. Forecast Revenue Growth

Oruka Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Oruka Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.31 per share.

* Oruka Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.